Variant report
Variant | nsv875796 |
---|---|
Chromosome Location | chr2:212845292-212874828 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs558599672 | chr2:212845853-212845854 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs578242178 | chr2:212845875-212845876 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs532788007 | chr2:212845881-212845882 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs563893988 | chr2:212845896-212845897 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs839542 | chr2:212845904-212845905 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs543106168 | chr2:212845908-212845909 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs559544292 | chr2:212845909-212845910 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs183678263 | chr2:212845912-212845913 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs534548134 | chr2:212845915-212845916 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs551328054 | chr2:212845938-212845939 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs139700625 | chr2:212845940-212845941 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs530699801 | chr2:212845974-212845975 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs12613571 | chr2:212845994-212845995 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs567450546 | chr2:212846018-212846019 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs554485391 | chr2:212846042-212846043 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs536011553 | chr2:212846051-212846052 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs565525351 | chr2:212846075-212846076 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs77756874 | chr2:212846076-212846077 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs566409159 | chr2:212846098-212846099 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs551454513 | chr2:212846101-212846102 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs569593296 | chr2:212846104-212846105 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs546745830 | chr2:212846138-212846139 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs558563592 | chr2:212846145-212846146 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs547930603 | chr2:212846175-212846176 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs12620013 | chr2:212846204-212846205 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs544121056 | chr2:212846270-212846271 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs557417218 | chr2:212846276-212846277 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs149843962 | chr2:212846324-212846325 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs542814262 | chr2:212846335-212846336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs559914333 | chr2:212846351-212846352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs114418987 | chr2:212846385-212846386 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs114524324 | chr2:212846424-212846425 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs17414974 | chr2:212846429-212846430 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs530859675 | chr2:212846473-212846474 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs550954566 | chr2:212846509-212846510 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs77254577 | chr2:212846525-212846526 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs148977001 | chr2:212846529-212846530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs191699513 | chr2:212846536-212846537 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs566556965 | chr2:212846540-212846541 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs536265949 | chr2:212846564-212846565 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs566697165 | chr2:212846602-212846603 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs184152743 | chr2:212846671-212846672 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs145598307 | chr2:212846687-212846688 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs189951339 | chr2:212846798-212846799 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs568870217 | chr2:212846801-212846802 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs537797095 | chr2:212846813-212846814 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs554560806 | chr2:212846814-212846815 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs147587110 | chr2:212846863-212846864 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs7563378 | chr2:212846898-212846899 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
50 | rs528961993 | chr2:212846907-212846908 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cervical cancer | 21062161 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Autism | 20808228 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Non-small cell lung cancer | 18676828 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chordoma | 18071362 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 18923514 | CNVD |
Schizophrenia | 22241247 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Developmental delay | 21147756 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Schizophrenia | 20838587 | CNVD |
Breast cancer | 17661082 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Schizophrenia | 18990708 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:212845800-212847400 | Enhancers | Fetal Heart | heart |
2 | chr2:212845800-212848200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr2:212845800-212848200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr2:212846400-212846600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
5 | chr2:212846400-212848000 | Enhancers | HUVEC | blood vessel |
6 | chr2:212847400-212853000 | Weak transcription | Fetal Heart | heart |
7 | chr2:212853000-212853800 | Enhancers | Fetal Heart | heart |
8 | chr2:212854600-212855200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
9 | chr2:212859400-212859800 | Enhancers | Skeletal Muscle Male | skeletal muscle |
10 | chr2:212859400-212859800 | Enhancers | Skeletal Muscle Female | skeletal muscle |
11 | chr2:212861400-212861800 | Enhancers | GM12878-XiMat | blood |
12 | chr2:212865000-212865200 | Enhancers | Brain Hippocampus Middle | brain |
13 | chr2:212865200-212865800 | Weak transcription | Brain Hippocampus Middle | brain |
14 | chr2:212865800-212866400 | Enhancers | Brain Anterior Caudate | brain |
15 | chr2:212865800-212866600 | Enhancers | Brain Hippocampus Middle | brain |
16 | chr2:212872600-212874400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
17 | chr2:212874200-212874800 | Enhancers | Brain Angular Gyrus | brain |
18 | chr2:212874400-212875800 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |